DCT Leadership GlobalCare's patient-centric decentralized trial capabilities, now integrated with Covance, position the combined entity to deliver scalable, globally distributed DCT programs for sponsors seeking broader geographic reach and patient-focused designs.

Global Expansion The Covance acquisition extends DCT offerings into new markets and enables cross-selling to Covance's sponsor base, accelerating access to international patient populations through remote enrollment, eConsent, and remote monitoring.

Tech Enablement A diverse technology stack including digital communication tools and data management platforms creates opportunities to modernize trial operations, enhance patient engagement, and deliver integrated data capture across sites.

Credible Positioning Industry recognition and a strong Covance-backed ecosystem signal reliability for sponsors seeking high-quality CRO partners, potentially shortening procurement cycles.

Growth Potential With a mid-sized team and global CRO backing, there is potential to expand service lines around DCT programs, patient-centric endpoints, and international recruitment to drive revenue growth.